Life Sciences
HRSA is scheduled to issue approvals to drugmakers by Oct. 15 for implementation of the pilot on Jan. 1, 2026.
The study aims to help people with speech and mobility challenges use the companies' technologies to interact using brain signals, eye gaze or head pose.
The company's platform predicts how people in a clinical trial will respond to treatment.
Thanks to the deal, Pfizer will avoid upcoming U.S. tariffs on overseas-made drugs for three years by offering discounted medications directly to American consumers.
The funds will be used to expand its customer base and invest in AI innovation.
IBM will help Infinitus apply agentic AI into specialty pharmacy workflows.
The company says a single node is capable of processing approximately 22,000 genomes annually, triple the amount of earlier releases.
Kakao Healthcare's partnership with Providence Health Care will also support its entry into the Canadian market.
T.Rx Capital aims to help companies build scalable platforms to reshape disease treatment.
Fabrx's pharmaceutical 3D printing platform is used for research and small batch manufacture of personalized medicine and medical devices.